drugset / Trial / NCT04061447
Tailored Juice-guided Eradication Therapy
RandomizedParallel-groupOpen-labelTreatment
Summary
In this study, the investigators aim to investigate the efficacy of tailored anti-microbial susceptibility guided-therapy via gastric juice PCR, compared with empirical standard triple therapy.
Timeline
- Start
- 2016-02-05
- Primary completion
- 2019-05-31
- Completion
- 2019-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amoxicillin | Other / unclassified | 1000 mg | — |
| Subject | Clarithromycin | Small molecule | 500 mg | — |
| Comparator | Levofloxacin | Small molecule | 500 mg | — |
| Comparator | Metronidazole | Small molecule | 500 mg | — |
| Subject | Rabeprazole | Small molecule | 20 mg | — |